Stamulumab

MYO-029 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Stamulumab, covering 2007-12-28 to 2007-12-28. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating MYO-029 in Adult Muscular Dystrophy [Phase 1, Phase 2]